First Real Estate Investment Trust: Comprehensive Equity Analysis Report

Executive Summary: Money Engine

First REIT generates cash through triple-net lease arrangements on 32 healthcare properties across Indonesia, Japan, and Singapore, distributing majority earnings through quarterly dividends while leveraging rental escalation mechanisms tied to tenant hospital revenues and local inflation indices.

Business Model Overview: Products and Problems Solved

First REIT operates as a healthcare real estate investor and lessor, addressing three core market problems: (1) capital requirements for healthcare operators to own rather than lease facilities, (2) geographic market entry barriers in healthcare real estate across developing Asia, and (3) yield-seeking demand from institutional investors in healthcare-backed income streams.

The REIT acquires income-producing healthcare real estate—primarily hospitals, nursing homes, and integrated healthcare facilities—and leases them to established healthcare operators under master lease agreements. The portfolio contains 15 hospitals and integrated facilities in Indonesia (74.5% of assets under management), 14 nursing homes in Japan (22.7%), and 3 nursing homes in Singapore (2.8%). Total portfolio value stands at S$1.14 billion with gross floor area of 448,744 square meters and capacity for 6,522 beds/rooms across all properties.

The REIT’s value proposition is passive, recurring rental income secured through long-term leases with built-in escalation protections. Rather than operating healthcare facilities, First REIT collects rent, maintains property standards, and manages tenant relationships—generating returns via triple-net lease economics where tenants pay base rent plus variable components tied to hospital operating performance.

Customer Base: Who Pays and Decision Factors

The REIT has 11 primary tenants operating across three countries, with pronounced concentration risk:

Decision-Making Structure: Healthcare operators (hospitals and nursing home chains) are the primary rent payers. Decision authority resides with operator management and boards, influenced by capital expenditure requirements, debt service capacity, and facility expansion strategies. Switching costs are exceptionally high—relocating healthcare operations disrupts patient relationships, specialist networks, and revenue streams, making lease termination economically irrational unless the facility becomes unsuitable for operations or financial distress forces asset sales.

Must-Have Factors: Tenants require long lease terms (minimum 10+ years preferred) to justify capital investments in equipment and renovation. Predictable rental structures with clear escalation mechanisms enable financial planning. Properties must meet accreditation standards and maintain occupancy above 85-90% to support rent payments. In Indonesia specifically, the rupiah’s historical volatility demands rent escalation tied to performance metrics rather than fixed currency exposure.

Switching Costs: Extremely high. Healthcare operators invest S$10-50m+ in facility buildout, IT systems, staff recruitment, and operational integration. Moving to alternative properties requires retraining, reputation rebuilding with patients/specialists, and potential revenue disruption. Estimated switching cost represents 1-2 years of accumulated profits, effectively permanent lock-in for well-performing operators.

2025 Strategic Wildcard: Siloam (39.9% of rentals) submitted a non-binding letter of intent in January 2025 to acquire First REIT’s Indonesia hospital portfolio. This reflects operator preference for ownership over leasing when capital is available. Siloam is majority-owned by CVC Capital Partners and has ample liquidity to pursue such acquisitions, creating material refinancing/restructuring risk for First REIT.

Revenue Model: Pricing Approach and Streams

Revenue Streams

Primary (>99% of revenue): Lease rental income from master lease agreements. FY2023 rental income was S$108.6 million on an S$1.14 billion portfolio, generating an implied gross yield of 9.5% (before expenses and debt service).

Escalation Mechanisms by Geography:

The Indonesia performance-based rent structure is the critical driver of long-term growth. In FY2023, rental growth in local currency (IDR) rose 7.6% with three hospitals paying performance-based rent. As Siloam’s revenue expands, its rental contribution grows automatically, creating a leveraged income stream. This is particularly powerful in Indonesia where healthcare utilization is growing rapidly (rising middle-class insurance penetration, urbanization, aging population).

Revenue Stability and Recurrence

Recurring Revenue: 100% of revenue is recurring—tenant rent payments occur monthly or quarterly under binding master lease agreements. No transactional revenue or one-time gains contribute meaningfully to operations.

Stability Profile: Exceptionally high. Portfolio occupancy rate is 100% (as at 31 March 2024), with all 11 tenants operating at or near full capacity. Lease expiries are staggered through 2043, with 73.4% of gross floor area committed beyond 10 years. Historical default rates among tenants are negligible—the sole significant arrear is from MPU (6.1% of rental income), which has committed to a repayment schedule as of mid-2025.

Revenue Cyclicality: Revenues are acyclical from macro-cycle perspective (healthcare demand is inelastic) but subject to:

• Foreign Exchange: 74.5% of portfolio revenue denominated in IDR; 22.7% in JPY. SGD/IDR depreciated ~2.4% in 1Q2024; SGD/JPY depreciated ~12.1% in same period. FX headwinds have consistently depressed reported DPU despite strong local-currency rental growth (+5.5% Indonesia in 1H2025).
• Tenant Operating Performance: Performance-based rent (8% of Indonesia hospitals’ GOR) exposes First REIT to operator profitability cycles. However, Siloam’s 41-hospital network provides diversification and recession resistance.
• Healthcare Utilization: Indonesian healthcare utilization grows with urbanization and middle-class expansion; Japan’s utilization is stable/growing with aging population; Singapore’s is mature.

Other Income: Minimal. Interest income from cash deposits was S$153k-331k quarterly in recent periods. Investment income does not materially affect results.

Pricing Power

Moderate to high within lease terms; limited between renewals. First REIT has built-in escalation of 4.5% + potential 8% performance variable in Indonesia and renegotiable terms every 2-5 years in Japan. However, renewal pricing is constrained by tenant exit options. Siloam’s January 2025 LOI signals that operators can exert pressure on rent levels when acquisition opportunities emerge. Fixed 2% Singapore escalation shows First REIT accepted lower pricing in that market likely due to competitive pressure from alternative facilities and shorter initial lease terms (10 years vs. 15 years in Indonesia).

Top Five Incumbents

Asia-Specific Competitive Landscape: First REIT is Singapore’s first and one of few pure-play healthcare REITs in Asia. Parkway Life REIT is the primary regional comparable. Columbia Asia is a healthcare operator (not a REIT) with hospitals in Indonesia, Malaysia, Vietnam, and India—not a direct competitor but occupies similar geographic/patient-demographic space. Most healthcare REIT competition is in North America and Europe where mature REIT markets, established legal frameworks, and consolidated hospital operators dominate.

First REIT’s Competitive Position: First REIT is the smallest healthcare REIT by absolute scale but occupies high-growth emerging markets (Indonesia’s healthcare market growing 8-12% CAGR; Japan’s aging-care market growing 4-6%). Yields are higher (9.4% DPU yield in FY2023) than developed-market peers due to emerging-market premium and smaller scale. Concentrated tenant base (top 2 tenants = 74.3% of rent) is a weakness vs. peers. Strategic position is transition-phase: recent Japan expansion (2022) and Indonesia restructuring (2020-2021) have positioned First REIT between distressed asset REIT (post-2020 crisis) and growth-stage emerging healthcare REIT.

Supply Side: Key Suppliers, Dependencies, and Bargaining Power

Supply Chain

First REIT’s supply chain is minimal—the REIT is a lessor, not an operator. Key dependencies:

1. Debt Providers (Banks/Capital Markets): Primary suppliers of capital for acquisitions and refinancing. As at 31 March 2024, First REIT has S$454.6 million in total debt across:

• S$233.7 million term loan due May 2026 (OCBC and CIMB)
• S$100.0 million CGIF-Guaranteed Social Bond due April 2027
• S$106.1 million TMK bond and loan due June 2030
• S$14.8 million Shinsei Social Loan due September 2026

87.2% of debt is fixed or hedged, providing interest rate stability. Cost of debt was 5.0% (FY2023), rising to 4.8% by mid-2025 as rates eased. Gearing ratio of 38.7% (Dec 2023) to 41.2% (June 2025) is moderate, leaving headroom for additional leverage if required for acquisitions. Lenders retain strong bargaining power due to high leverage multiples in REITs and refinancing requirements every 2-4 years. May 2026 refinancing of S$233.7 million represents material refinancing risk in rising-rate environment.

Bargaining Power Assessment: Moderate-to-High for lenders. First REIT is smaller than institutional-grade peers (Welltower, Ventas) and emerging-market exposure elevates perceived risk. No refinancing requirements until May 2026 mitigates near-term pressure. Interest coverage ratio of 3.7-4.1x is adequate but not fortress-like (vs. 5.0x+ for large REITs).

2. Equity Capital / Unitholder Base: First REIT has 2.1 billion units issued as of mid-2025. Sponsors (OUE Limited and OUE Lippo Healthcare Limited) own 44.8% of units, providing alignment. No significant activist pressure reported, though the Siloam LOI (January 2025) may attract activist interest if valuation concerns surface. Unitholders have limited direct bargaining power post-IPO; strategic options flow through management and the board.

3. Property Vendors/Acquisition Counterparties: Historically, First REIT has acquired properties from sponsors (OUE, OUELH) under right-of-first-refusal arrangements. This limits external vendor competition but subjects First REIT to related-party transaction scrutiny and pricing fairness concerns. The January 2025 Siloam LOI suggests potential shift toward inbound M&A interest (operator-led acquisitions) rather than outbound acquisition activity.

4. Service Providers (Property Management, Valuers, Legal/Audit): Commodity-like services. Multiple providers available; limited bargaining power leverage. Property operating expenses averaged S$41.6 million in FY2023 on S$108.6 million revenue (38.3% opex ratio), in line with healthcare REIT norms. No material supplier concentration risk in property management layer.

Supply-Side Constraints on Growth

• Refinancing Requirements: S$233.7 million due May 2026 must be refinanced or repaid, constraining capital deployment for acquisitions in 1H 2026.
• Gearing Limits: At 41.2%, First REIT has limited debt capacity for acquisitions without equity dilution. Sponsors (44.8% ownership) would likely resist excessive equity issuance.
• Sponsor ROFR Constraints: First REIT has right-of-first-refusal from OUE Lippo Healthcare and Lippo Karawaci to acquire pipeline assets. However, this creates dependency on sponsor asset quality and may limit external deal flow.
• Tenant Acquisition Competition: Healthcare operators (Siloam, Columbia Asia, etc.) are increasingly acquiring properties themselves rather than leasing, as evidenced by Siloam’s January 2025 LOI. This reduces available external acquisition targets.

Competitive Advantages and Moats

1. Long-Term Lease Contracts with Embedded Escalation (Contractual Moat)

Core strength. First REIT’s master lease agreements feature:

• Indonesia: 15-year initial terms (to 2035) with option for 15-year renewal; escalation is higher of 4.5% fixed or 8% of hospital GOR. This structure provides revenue visibility and performance linkage.
• Japan: Predominantly 30-year leases with 5-year renewal options through 2043; negotiated escalation every 2-5 years. Provides 17.7-year weighted average lease expiry, one of the longest among Asian healthcare REITs.
• Singapore: 10-year leases with renewal options; 2% annual escalation. Shortest expiry profile (3.1 years WALE) is a weakness.

Switching costs for tenants are extreme (1-2 years of profitability to relocate), creating effective contract lock-in. Embedded escalation ties revenue growth to inflation and tenant performance, protecting real returns.

Moat Durability: Contracts are inviolable except through mutual agreement or tenant default. However, Siloam’s January 2025 LOI signals operator preference for ownership when acquisition is feasible. Moat is strong but not permanent—acquisition pressure may force renegotiation over 5-10 year horizon.

2. Essential Healthcare Real Estate (Regulatory/Operational Moat)

Healthcare properties are indivisible from healthcare operations. Regulators (Ministry of Health in Indonesia, MHLW in Japan) enforce facility standards that effectively grant incumbent status to well-positioned operators and REITs. New entrants face:

• Accreditation and licensing requirements (2-3 years to obtain)
• Established physician networks and patient referral relationships
• Capital-intensive facility standards (minimum 500 beds for tertiary hospitals, specific ICU/isolation requirements)

First REIT’s properties are already accredited and operating, creating entry barriers for new competitors. However, this moat protects operators (Siloam, LPKR) more than the REIT lessor.

3. Emerging Market Healthcare Growth Tailwind (Macro/Secular Moat)

Indonesia and Japan are experiencing structural healthcare demand drivers:

This is a genuine 10-year moat, not dependent on First REIT’s actions. However, it benefits tenants (operator revenue growth) more directly than the REIT (which captures escalation through lease terms).

4. Sponsor Relationships and ROFR (Relational Moat)

First REIT has right-of-first-refusal to acquire assets from:

• OUE Lippo Healthcare Limited (OUELH): 100% ownership of First REIT Manager; direct access to OUE/Lippo pipeline
• Lippo Karawaci Tbk (LPKR): Major shareholder of Siloam; access to hospital pipeline in Indonesia

This ROFR provides deal flow advantage vs. external competitors. However, it also creates dependency on sponsor asset quality and pricing fairness. In a rising interest rate environment or if sponsors face capital constraints, pipeline may dry up.

Moat Strength: Moderate. ROFR is valuable but not durable if sponsors elect to sell or operate assets directly.

5. Geographic Diversification (Risk Mitigation, Not True Moat)

Portfolio is diversified across Indonesia (74.5%), Japan (22.7%), and Singapore (2.8%), reducing single-country risk. However, Indonesia concentration remains extreme (nearly 3/4 of revenue from one country). Japan expansion (2022) was intended to diversify; however, it created new currency risk (JPY weakness) without reducing Indonesia dependence.

Moat Assessment: Weak. Diversification is helpful for risk mitigation but does not create competitive advantage vs. peers.

Summary Moat Assessment

First REIT has moderately strong moats centered on long-term contracts with embedded escalation and access to a growing pool of healthcare demand in emerging markets. The moat is strongest in Indonesia (where performance-based rent ties revenue to operator success) and longest-dated in Japan (17.7-year WALE). However, moats are under stress from operator consolidation (Siloam wanting to acquire properties) and currency volatility. Overall: Medium-strength moat; defensible but not growing stronger.

Industry Context and Competitive Positioning

Market Structure

The REIT sector is bifurcated by development geography:

Developed Markets (North America, Europe, Australia): Mature, consolidated REIT ecosystem with thousands of properties, professional management, deep capital markets, and scale economies. Top 10 healthcare REITs represent ~70% of sector capitalization. Competition is intense; differentiation is minimal; yields are lower (2-4%).

Emerging Markets (Asia, Latin America, Middle East): Nascent REIT markets with limited players. Asian healthcare REITs are rare; institutional investors are underweight due to perceived governance and liquidity risks. First REIT is one of the few pure-play emerging-market healthcare REITs with significant scale in Indonesia and Japan. Yields are higher (8-12%) reflecting illiquidity and country risk premiums.

First REIT operates in the emerging-market healthcare REIT niche—a high-yield, lower-liquidity, higher-growth segment with fewer competitors but more regulatory/currency risks than developed-market peers.

Competitive Positioning Within Asia

vs. Parkway Life REIT (Singapore: C2PU): Parkway is larger (S$1.8-2.0B vs. First REIT’s S$1.14B), more diversified geographically (Singapore, Japan, France), and commands a higher valuation multiple (P/NAV 2.0x vs. 0.73x for First REIT). Parkway has higher WALE (17+ years) and more predictable lease escalation. First REIT’s DPU yield is higher (9.4% vs. Parkway’s lower yield), suggesting cheaper valuation or higher risk perception. First REIT has stronger performance-based rent exposure (Indonesia upside) but higher tenant concentration risk (Siloam + LPKR = 74.3% of rent vs. Parkway’s more diversified base).

Positioning Assessment: First REIT is a “high-yield, concentrated, emerging-market” play; Parkway is a “quality, diversified, regional” play. For yield seekers with emerging-market risk tolerance, First REIT is competitive. For institutional investors prioritizing stability and diversification, Parkway is preferable.

Main Competitors

• Parkway Life REIT: Direct regional comparable; larger, more stable, higher quality perceived by market.
• Columbia Asia: Healthcare operator (not REIT) in similar geographies; competitive for tenant acquisition but not for REIT investors.
• Welltower, Ventas, MPW (USA): Institutional-grade alternatives; much larger scale; lower yields; developed-market focus.
• Untraded healthcare operators owning property (Siloam, LPKR, Apollo, Max Healthcare): Represent alternative investment vehicles for healthcare real estate; private equity-backed players may acquire properties directly (as Siloam’s January 2025 LOI signals).

First REIT is best positioned for yield-focused investors with emerging-market risk tolerance and 3-5 year holding horizons. Institutional long-term investors may prefer Parkway or larger developed-market peers.

Growth Drivers: Pricing Power, Upsell, New Markets, M&A

1. Pricing Power / Escalation (Primary Driver)

Indonesia Performance-Based Rent: The largest growth opportunity. Escalation is higher of 4.5% fixed or 8% of hospital gross operating revenue. As Siloam’s revenue grows (18% YoY in 9M2023), rental income grows automatically. In FY2023, rental growth in IDR was 7.6% despite reported SGD decline (due to currency). If Siloam can sustain 8-12% annual revenue growth, performance-based rent will escalate at 8% annually in IDR terms, translating to 4-6% SGD-denominated growth after currency volatility—a meaningful uplift.

Japan Escalation (Moderate): Renegotiated every 2-5 years based on CPI and interest rates. Expected escalation is 1-3% annually in JPY terms, depressed by Japan’s low inflation environment (0.5-2% CPI). Limited upside from inflation; primarily maintenance of real returns.

Singapore Escalation (Weak): Fixed 2% annually. Lowest-growth component; pricing power is minimal due to competitive nursing home market in Singapore.

Overall Pricing Power Assessment: MODERATE TO HIGH in Indonesia (performance-based), LOW in Singapore, MODERATE in Japan. Blended portfolio growth is constrained by currency headwinds and limited Singapore escalation, but underlying local-currency growth is resilient.

2. Upsell / Portfolio Optimization (Moderate Driver)

First REIT has limited upsell opportunities—the REIT is not an operator and does not provide ancillary services. However, portfolio optimization involves:

• Asset-Specific Rent Renegotiations: Three Indonesia hospitals (Sriwijaya, Purwakarta, Kebon Jeruk) contributed performance-based rent in FY2023, indicating they exceeded base rent thresholds. As hospital performance improves, more properties will trigger performance escalation. Estimated incremental rent from broader performance-based rent take-up: S$2-5 million annually by 2028 (if 6-8 additional hospitals reach performance rent thresholds).
• Capital Improvement Potential: First REIT can invest in property upgrades (e.g., new ICU wings, diagnostic equipment, renovations) to support tenant operators’ revenue growth and justify higher rents at renewal. Capital expenditure in FY2023 was minimal; potential exists to invest S$5-10 million annually in selective upgrades to unlock rent growth.
• Singapore Lease Renegotiation (2027): All three Singapore nursing homes expire in April 2027. Renegotiation opportunity exists to improve escalation terms (from 2% to 3-4% if market conditions support) or secure longer lease terms. This is limited upside—Singapore properties represent only 2.8% of AUM.

Upsell Potential Assessment: MODEST. Limited scope to materially improve rent without operational involvement (which First REIT cannot pursue). Most growth must come from tenant revenue growth, not REIT initiatives.

3. New Market Entry (Near-Term Limited, Medium-Term Possible)

First REIT’s 2.0 Growth Strategy (launched December 2021) includes target to increase developed-market exposure to >50% of AUM by FY2027 (from 25.5% as at 31 Dec 2023). This requires S$550-650 million of incremental developed-market acquisitions over next 2-3 years.

Geographic Expansion Opportunities:

• Thailand: Growing healthcare market; aging population; ASEAN economic hub. No current First REIT presence. Potential for nursing home/specialty hospital expansion similar to Japan model.
• Vietnam: Rapid healthcare utilization growth; middle-class expansion; hospital operator consolidation underway. Potential for partnership with regional operators or sponsor pipeline.
• India: Massive healthcare market; but political/regulatory risk is high; currency volatility significant. Probably out of scope given First REIT’s risk tolerance.
• Australia / South Korea: Developed markets with mature REIT frameworks; opportunities exist but competition from larger incumbents is intense.

Near-Term Constraint: S$233.7 million refinancing due May 2026 limits capital deployment. Strategic review (triggered by Siloam’s LOI) creates uncertainty on direction. Most likely outcome: First REIT will hold portfolio through 2026 refinancing, then pursue selective M&A in Japan/Singapore or opportunistic acquisitions if developed-market targets emerge at attractive yields.

New Market Potential: LIMITED IN NEAR TERM (2025-2026); MODERATE IN MEDIUM TERM (2027-2030). Geographic expansion requires capital availability (post-refinancing) and strategic clarity (post-Siloam LOI outcome).

4. M&A: Acquisitions and Divestitures (High Impact, High Uncertainty)

Outbound M&A (Acquisitions by First REIT):

First REIT announced a preliminary non-binding letter of intent from Siloam on January 13, 2025, to acquire First REIT’s Indonesia hospital portfolio. This is inbound M&A (operator acquiring properties from REIT), not outbound. Management appointed Citigroup to conduct strategic review and explore alternatives. Potential outcomes:

1. Sale to Siloam (High Impact, >50% Probability): Siloam acquires S$849 million Indonesia portfolio (74.5% of AUM). First REIT would receive ~S$800-900 million in cash/equity. REIT would be restructured around Japan (22.7%) and Singapore (2.8%) assets—total AUM S$300-350 million. This scenario creates: (a) Major capital event; (b) Refinancing risk if sale prices below book value; (c) Strategic fork—REIT could redeploy capital into developed markets OR return capital to unitholders. Likely outcome if consummated: 30-50% unit price upside (unlocking embedded value) but long-term distributions decline 40-50%.
2. Strategic Partnership / Joint Venture (Moderate Probability, ~20%): Rather than outright sale, First REIT and Siloam structure JV where Siloam acquires 50%+ stake, Siloam assumes operational risk, First REIT retains revenue participation. Could unlock S$300-500 million in liquidity. JV model is growing in REIT space. Less disruptive than outright sale but creates governance complexity.
3. No Transaction / Status Quo (Moderate Probability, ~20%): Strategic review concludes no sale is optimal. First REIT retains full Indonesia portfolio; pursues Japan/Singapore growth and selective acquisitions. Distributions stabilize once FX headwinds ease. Risk: Unitholder activism if transaction is perceived as missed value realization.
4. Divestitures / Portfolio Optimization (Ongoing): Imperial Aryaduta Hotel & Country Club (non-core, 1.6% of revenue) is being marketed for sale. Divestiture would raise S$30-50 million, further reducing portfolio concentration.

Inbound Portfolio Opportunities: First REIT has ROFR from OUE Lippo Healthcare and Lippo Karawaci to acquire pipeline assets. However, no major acquisitions have been announced since Japan nursing homes (2022). Pipeline visibility is limited by sponsor financial constraints (LPKR faced liquidity pressure in 2020).

M&A Assessment: HIGH IMPACT in near term (2025-2027); STRATEGIC OUTCOME IS PRIMARY VALUATION DRIVER. Siloam LOI is transformational event creating option value for unitholders. If consummated at attractive valuation (premium to book value), would unlock latent shareholder value. If rejected or unfavorable terms, REIT reverts to steady-state yield vehicle with limited growth catalysts.

Expected Growth 2025-2027 (Base Case Assumptions):

• Reported DPU growth: -2% to +1% annually (FX headwinds offset local-currency escalation)
• Local-currency DPU growth (Indonesia): +5-7% annually (performance-based rent)
• M&A-driven upside: +30-50% if Siloam transaction consummated at fair value
• M&A-driven downside: -10-20% if sale occurs at distressed valuation or if no transaction occurs and market penalizes lost optionality

Risk Checklist: Operational, Financial, Regulatory, ESG

Short Interest Evolution

First REIT (SGX: AW9U) is not widely shorted. Public short interest data is limited for SGX-listed securities, but available indicators suggest short interest is <1% of shares outstanding. The REIT's modest liquidity and concentrated unitholder base (sponsors hold 44.8%) likely suppress short-selling activity. No material short squeeze risk or activist short campaigns have been reported. Short interest is not a material valuation factor for First REIT.

Comparative Note: First Industrial Realty Trust (NYSE: FR), a US-listed industrial REIT, has short interest of 2.8% (as of July 31, 2025) and short ratio of 2.9 days to cover. This is typical for large-cap US REITs. First REIT’s lack of significant short interest reflects its smaller scale and emerging-market profile.

Historical Evolution: Business Model Transformation Over 5-10 Years

FY2014-2019: Stable Indonesia Operator-Lease Model

Period Characteristics: First REIT was predominantly an Indonesia-focused healthcare REIT leasing 11 hospitals to LPKR. Portfolio was S$450-550 million. DPU was stable at 8.0-8.6 cents annually, yielding 9-10% on unit price of S$0.90-1.00.

Business Model: Triple-net lease on established hospitals under LPKR’s brand (Siloam and legacy LPKR hospitals). Fixed escalation was capped at 2% annually (low). LPKR managed all tenant revenue risk. First REIT’s role was passive landlord collecting rent and maintaining properties.

Key Events:

• 2018: LPKR faced first debt crisis; First REIT unit price fell 30-40% as market repriced LPKR default risk onto First REIT
• 2019: Recovery as LPKR stabilized; DPU maintained at 8.60 cents

Weakness of Model: Extreme tenant concentration (72.1% from LPKR hospitals); no tenant revenue linkage (fixed 2% escalation was low relative to operator inflation); no geographic diversification; high refinement risk from LPKR sponsor liquidity stress.

FY2020-2021: Crisis and Restructuring

Catalyst: COVID-19 pandemic disrupted healthcare operations; LPKR unilaterally announced rent restructuring plans on June 1, 2020, citing liquidity pressure and currency weakness (IDR depreciated ~45% vs. SGD since First REIT IPO in 2006).

Restructuring Details:

• Master lease agreements extended from 2021 expiry to December 31, 2035 (14 years)
• Rental currency switched from SGD to IDR, eliminating FX exposure for tenants but increasing First REIT’s currency risk
• Base rent escalation increased from 2.0% to 4.5% to compensate for currency risk
• Performance-based rent component introduced: 8% of hospital gross operating revenue in preceding year (whichever is higher)
• Siloam added as co-tenant on LPKR leases, improving tenant credit quality

Strategic Outcome: First REIT avoided near-certain default of LPKR. WALE extended from 6.4 years to 12.3 years. Rent escalation improved from fixed 2% to variable 4.5-8%. LPKR’s financial distress was contained through restructure rather than foreclosure.

Market Impact: Unit price initially fell to S$0.24-0.35 (distressed levels); recovered to S$0.45-0.55 by end of 2020 as market repriced restructuring favorably. DPU fell to 7-8 cents as distributable income was depressed by restructuring impact and higher interest costs on refinancing.

FY2022-2023: Geographic Diversification and Growth Strategy

Strategic Shift: First REIT 2.0 Growth Strategy launched in December 2021 with four pillars: (1) diversify into developed markets; (2) reshape portfolio for capital efficiency; (3) strengthen capital structure; (4) ride demographic megatrends.

Major M&A: Japan Nursing Home Acquisition

• January 28, 2022: Unitholder vote approved acquisition of 12 nursing homes in Japan from sponsor OUE Lippo Healthcare (98.45% approval)
• Acquisition cost: ~S$190 million (funded through rights issue and debt)
• Completed in phases through 2022; 14 total nursing homes in Japan as at end-2023
• Strategic rationale: (a) Developed markets exposure increased from 3.4% to 25.5% of AUM; (b) Japan eldercare market growing 4-6% CAGR as population ages; (c) Lower currency risk vs. Indonesia Rupiah; (d) Longer lease terms (30 years with 5-year renewal options)

Financing Actions:

• April 2022: Issued Singapore’s first healthcare social bond (S$100 million) to institutional investors, demonstrating market appetite for healthcare REIT debt
• November 2022: Refinanced S$260 million term loan with S$300 million social term loan (June 2026 maturity)
• June 2023: Early refinancing of TMK bond due May 2025

Portfolio Evolution: AUM grew from ~S$550m (pre-Japan) to S$1.14 billion. Indonesia concentration fell from ~95% to 74.5%. Japan exposure rose from 0% to 22.7%. WALE extended through long-dated Japan leases.

Financial Performance: Despite AUM growth, DPU declined from 10.2 cents (FY2022) to 9.4 cents (FY2023) and 2.48 cents (FY2024) due to: (a) currency headwinds (IDR/JPY weakness); (b) higher interest costs from refinancing; (c) unit dilution from rights issue and management fee settlements in units.

FY2024-Present: Currency Headwinds and Strategic Review

Performance Headwinds: Reported DPU declined to 2.36 cents (FY2024) and 1.13 cents (1H 2025), down 7.3% YoY for 9M 2025. Despite strong local-currency rental growth (+5.5% Indonesia, +2.0% Singapore, stable Japan), reported results are suppressed by currency translation:

• SGD/IDR depreciation reducing reported income from Indonesia (74.5% of portfolio)
• SGD/JPY depreciation reducing reported income from Japan (22.7% of portfolio)

Strategic Turning Point (January 2025): First REIT received non-binding letter of intent from Siloam to acquire Indonesia hospital portfolio (S$849 million, 74.5% of AUM). This signals potential pivot from growth-stage REIT to asset-light investment company or restructured entity focused on Japan/Singapore. Strategic review underway with Citigroup.

Business Model Implications:

Over 10 years, First REIT has transformed from:

• 2014: Indonesia-focused, sponsor-dependent, operator-lease model
• 2021: Indonesia-concentrated, restructured leases, crisis-managed entity
• 2023: Diversified geographically, growth-stage REIT with developed-market exposure
• 2025: Uncertain—potential inflection point where largest tenant (Siloam) acquires assets, forcing REIT to reinvent or return capital to unitholders

The business model has evolved from distressed/opportunistic operator-lease play to institutional healthcare REIT with growth aspirations to potential transaction vehicle or modified REIT. Key inflection points were: (a) 2020 restructuring (survival); (b) 2022 Japan acquisition (growth); (c) 2025 Siloam LOI (transformation).

Comprehensive Risk Checklist (Summary Table)

Five-Point Investor Takeaway

Valuation Summary

P/NAV Multiple: 0.73x (as reported in FY2021 analyst research); estimated at 0.65-0.75x in 2025 based on recent market prices (S$0.24-0.30 range) vs. NAV/unit of ~30 cents (as at 31 Dec 2023) and 29.48 cents (as at 31 Mar 2024).

DPU Yield (Normalized): 9.4% on FY2023 reported DPU of 2.48 cents (annualized), down to 8.4% on 1H 2025 projected annualized DPU of ~2.3 cents due to FX headwinds.

Valuation vs. Peers: First REIT trades at significant discount to Parkway Life REIT (P/NAV 2.0x) and established healthcare REITs (Welltower at 1.8x, Ventas at 1.5x). Discount reflects: (a) emerging-market risk premium; (b) tenant concentration; (c) currency volatility; (d) smaller scale/less liquidity; (e) strategic uncertainty from Siloam LOI.

Fair Value Range: Based on peer multiples (1.2-1.5x P/NAV) and comparable healthcare REIT yields (5-7%), fair value for First REIT is estimated at S$0.35-0.45 per unit (vs. current price of S$0.24-0.30), implying 20-50% upside depending on: (a) resolution of Siloam LOI; (b) stabilization of FX; (c) management execution of growth strategy.